Study types
- other 3
- case-report 1
Condition tags
- endometriosis 3
- dysmenorrhea 2
- infertility 1
- endometrioma 1
- adenomyosis 1
Top journals
Frequent coauthors
- Yu-Hsiang Shih 4
- Lu CH 3
- Chien-Hsing Lu 3
- Lu TF 2
- Lou Sun 2
- Chen TM 2
- Jenn-Jhy Tseng 2
- Hsu ST 2
- Chiang YF 2
- H. Sunny Sun 2
BACKGROUND: Endometriosis is a chronic, estrogen-dependent condition associated with substantial physical and psychological burden. Although psychiatric comorbidities are frequently reported, large-scale real-world data remain limited. MET…
BACKGROUND: Emerging evidence suggests a potential link between endometriosis and thyroid disorders; however, long-term risks remain understudied. METHODS: We conducted a retrospective cohort study using data from the TriNetX global Collab…
BACKGROUND: Patients with adenomyosis frequently experience menorrhagia and dysmenorrhea. Levonorgestrel-releasing intrauterine device (LNG-IUD) and oral norethindrone are widely used non-surgical treatment options. However, their associate…
Endometriosis is a benign disease, which is also regarded as a precursor to ovarian malignancy. Dienogest is a progestin treatment for endometriosis with efficacy and tolerability. A 35-year-old Taiwanese lady with ovarian endometrioma had …
Salvia sclarea essential oil is used as an aromatic therapy for dysmenorrhea. Sclareol-one of the natural products isolated from S. sclarea-displays anti-inflammatory and antioxidant activities; however, researchers have not yet evaluated t…
Human fibroblast growth factor 9 (FGF9) is a potent mitogen involved in many physiological processes. Although FGF9 messenger RNA (mRNA) is ubiquitously expressed in embryos, FGF9 protein expression is generally low and restricted to a few …
A TG microsatellite in the 3'-untranslated region (UTR) of FGF9 mRNA has previously been shown to modulate FGF9 expression. In the present study, we investigate the possible interacting protein that binds to FGF9 3'-UTR UG-repeat and study …